TY - JOUR
T1 - Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness
AU - Chong, Rachel S.
AU - Chee, Miao Li
AU - Tham, Yih Chung
AU - Majithia, Shivani
AU - Thakur, Sahil
AU - Teo, Zhen Ling
AU - Da Soh, Zhi
AU - Chua, Jacqueline
AU - Tan, Bingyao
AU - Wong, Damon W.K.
AU - Schmetterer, Leopold
AU - Sabanayagam, Charumathi
AU - Cheng, Ching Yu
N1 - Publisher Copyright:
© 2020 American Academy of Ophthalmology
PY - 2021/3
Y1 - 2021/3
N2 - Purpose: To evaluate the association between different classes of antihypertensive medication with retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness in a nonglaucomatous multiethnic Asian population. Design: Population-based, cross-sectional study. Participants: A total of 9144 eyes for RNFL analysis (2668 Malays, 3554 Indians, and 2922 Chinese) and 8549 eyes for GC-IPL analysis (2460 Malays, 3230 Indians, and 2859 Chinese) aged 44 to 86 years. Methods: Participants underwent standardized systemic and ocular examinations and interviewer-administered questionnaires for collection of data on medication and other variables. Intraocular pressure (IOP) readings were obtained by Goldmann applanation tonometry before pupil dilation for fundoscopy and OCT imaging. Blood pressure (BP) was measured with an automatic BP monitor. Mean arterial pressure (MAP) was defined as diastolic BP plus 1/3 (systolic BP – diastolic BP). Regression models were used to investigate the association of antihypertensive medication with OCT measurements of RNFL and GC-IPL. Main Outcome Measures: Average and sectoral RNFL and GC-IPL thickness. Results: After adjusting for age, gender, ethnicity, MAP, IOP, body mass index (BMI), and presence of diabetes, we found that participants taking any type of antihypertensive medication (β = −0.83; 95% confidence interval [CI], −1.46 to −0.02; P = 0.01), specifically angiotensin-converting enzyme inhibitors (ACEIs) (β = −1.66; 95% CI, −2.57 to −0.75; P < 0.001) or diuretics (β = −1.38; 95% CI, −2.59 to −0.17; P < 0.05), had thinner average RNFL in comparison with participants who were not receiving antihypertensive treatment. Use of a greater number of antihypertensive medications was significantly associated with thinner average RNFL (P for trend = 0.001). This association was most evident in the inferior RNFL quadrant in participants using ACEIs (β = −2.44; 95% CI, −3.99 to −0.89; P = 0.002) or diuretics (β = −2.76; 95% CI, −4.76 to −0.76; P = 0.007). A similar trend was noted in our analysis of macular GC-IPL thickness. Conclusions: Use of 2 or more antihypertensive medications, ACEI, and diuretics were associated with a loss of structural markers of retinal ganglion cell health in a multiethnic Asian population.
AB - Purpose: To evaluate the association between different classes of antihypertensive medication with retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness in a nonglaucomatous multiethnic Asian population. Design: Population-based, cross-sectional study. Participants: A total of 9144 eyes for RNFL analysis (2668 Malays, 3554 Indians, and 2922 Chinese) and 8549 eyes for GC-IPL analysis (2460 Malays, 3230 Indians, and 2859 Chinese) aged 44 to 86 years. Methods: Participants underwent standardized systemic and ocular examinations and interviewer-administered questionnaires for collection of data on medication and other variables. Intraocular pressure (IOP) readings were obtained by Goldmann applanation tonometry before pupil dilation for fundoscopy and OCT imaging. Blood pressure (BP) was measured with an automatic BP monitor. Mean arterial pressure (MAP) was defined as diastolic BP plus 1/3 (systolic BP – diastolic BP). Regression models were used to investigate the association of antihypertensive medication with OCT measurements of RNFL and GC-IPL. Main Outcome Measures: Average and sectoral RNFL and GC-IPL thickness. Results: After adjusting for age, gender, ethnicity, MAP, IOP, body mass index (BMI), and presence of diabetes, we found that participants taking any type of antihypertensive medication (β = −0.83; 95% confidence interval [CI], −1.46 to −0.02; P = 0.01), specifically angiotensin-converting enzyme inhibitors (ACEIs) (β = −1.66; 95% CI, −2.57 to −0.75; P < 0.001) or diuretics (β = −1.38; 95% CI, −2.59 to −0.17; P < 0.05), had thinner average RNFL in comparison with participants who were not receiving antihypertensive treatment. Use of a greater number of antihypertensive medications was significantly associated with thinner average RNFL (P for trend = 0.001). This association was most evident in the inferior RNFL quadrant in participants using ACEIs (β = −2.44; 95% CI, −3.99 to −0.89; P = 0.002) or diuretics (β = −2.76; 95% CI, −4.76 to −0.76; P = 0.007). A similar trend was noted in our analysis of macular GC-IPL thickness. Conclusions: Use of 2 or more antihypertensive medications, ACEI, and diuretics were associated with a loss of structural markers of retinal ganglion cell health in a multiethnic Asian population.
KW - anti-hypertensive
KW - GC-IPL
KW - glaucoma
KW - hypertension
KW - medication
KW - OCT
KW - RNFL
KW - systemic medication
UR - http://www.scopus.com/inward/record.url?scp=85090314264&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090314264&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2020.07.051
DO - 10.1016/j.ophtha.2020.07.051
M3 - Article
C2 - 32739337
AN - SCOPUS:85090314264
SN - 0161-6420
VL - 128
SP - 393
EP - 400
JO - Ophthalmology
JF - Ophthalmology
IS - 3
ER -